AXL-IN-13
AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM. It exhibits anticancer activity, reverses TGF-β1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion.
Product Specifications
CAS Number
2376928-82-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
632.72
Molecular Formula
C34H41FN6O5
Notes
Research use only, not for human use.
Receptor
FLT | PDGFR | TGF-beta/Smad | TAM Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6394107-01 0.1 mL
SH2D3C (SH2 Domain-Containing Protein 3C, Novel SH2-Containing Protein 3, NSP3, UNQ272/PRO309/PRO34088) (MaxLight 405)
Sign In for Pricing
View Details MBS6394107-02 5x 0.1 mL
SH2D3C (SH2 Domain-Containing Protein 3C, Novel SH2-Containing Protein 3, NSP3, UNQ272/PRO309/PRO34088) (MaxLight 405)
Sign In for Pricing
View Details 
MBS6244216-01 0.1 mL
STAT5a,b, phosphorylated (Tyr694/Tyr699) (Signal Transducer and Activator of Transcription 5a,b) (PE)
Sign In for Pricing
View Details